
SIBN — Si-Bone Inc
NASDAQ · Healthcare · Medical Devices
$19.21
+$0.29 (+1.54%)
Si-Bone Inc (SIBN) is a medical devices company listed on NASDAQ. It is led by Laura A. Francis MBA, based in 471 El Camino Real, Santa Clara, CA, United States, 95050, with about 376 employees. SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium. The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.
Latest reported SIBN revenue for 2025-09-30 was $48.7M. Net income was -$4.6M. Revenue was up 0.1% from 2025-06-30 to 2025-09-30. SIBN currently screens at market cap $674.6M.
Use this SIBN page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the SIBN quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the SIBN SEC filings page. Lician reads the product cache first so this HTML stays unique to Si-Bone Inc even when a live quote feed is slow.
About Si-Bone Inc
SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium. The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.
SIBN Key Statistics
Market Cap
$674.55M
Volume
600,032
Previous Close
$19.54
Day Range
$19.24 – $19.95
P/B Ratio
3.77
EPS
-$0.75
Revenue
$167.18M
Net Income
-$30.91M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+20.4%
Profit Margin
-18.5%
Employees
376
SIBN Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $167.18M | $138.89M | $106.41M | $90.15M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$30.91M | -$43.34M | -$61.26M | -$56.57M |
| EPS (Diluted) | -$0.75 | -$1.13 | -$1.79 | -$1.71 |
Total Assets
$230.44M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$34.95M
Operating Cash Flow
-$12.43M
Free Cash Flow
$0.00
Si-Bone Inc Company Information
- CEO & Director
- Laura A. Francis MBA
- Headquarters
- 471 El Camino Real, Santa Clara, CA, United States, 95050
- Website
- si-bone.com
- Phone
- 408 207 0700
- IPO / Founded
- 2018-10-17
- Sector
- Healthcare
- Industry
- Medical Devices